Apr 2, 2021|
JD Health to Provide Services for Children with Autism
by Vivian Yang
JD Health and PKUcare Brain Health, China’s leading research and treatment platform for childhood psychiatric health, announced to build a platform for children with autism on Apr. 2, World Autism Awareness Day.
The platform will bring online and offline resources together to create one-stop services that range from knowledge popularization, medical screening, and diagnosis to rehabilitation for children with mental health disorders.
“The treatment and rehabilitation for children with autism spectrum disorder and other mental disorders is often a long-term process. Our collaboration with JD Health will concentrate more premier resources to provide continued and tailored support to our child patients and their families,” said Lei Wang, general manager of PKUCare Brain Health at the cooperation agreement signing ceremony in Beijing.
Fangyi Jin (left) and Lei Wang (right) at the signing ceremony
The two sides will work together to form a nationwide network to carry out child development screening, diagnosis and rehabilitation for children up to age 14, and provide tools, medicines, pharmaceutical products and life necessities for 500,000 medical workers and caregivers in primary hospitals and healthcare centers to improve their service capabilities.
JD Health will also provide patients with constant health management services including online consultation, doctor revisiting, periodic follow-ups and more. Besides, the company will work with PKUCare Brain Health on developing healthcare and rehabilitation products to offer more diversified and affordable choices for patients.
Since its launch in April 2020, JD Health’s online psychological consultation platform has been active in cooperating with doctors, hospitals and industry associations to bring high-quality psychological treatment online. The platform now has more than 7,000 psychologists who can provide customers with timely and convenient advice not only during their online consultation process but also when customers select medicines on JD Health that have high relevance to mental illnesses, offering early intervention in the treatment process.
“For children with mental health development disorders, early testing, diagnosis and intervention are key to effective treatment and rehabilitation,” noted Fangyi Jin, general manager of specialized internet hospitals of JD Health, “JD Health will continue to strengthen collaboration with PKUCare Brain Health and other industry partners to provide efficient and long-term healthcare services for children in need, helping them to better fit into society and letting their families enjoy a healthy and happier life.”
The healthcare platform for children with autism on JD Health
According to PKUCare Brain Health’s report, China has about three million children with autism. The platform aims to cover over 140 million people in China affected by autism including the children themselves and their family members.
PKUCare Brain Health is under Peking University’s healthcare group and co-founded by Peking University’s Sixth Hospital that specializes in clinical psychiatric studies. By the end of 2019, the company has supported over 250,000 children with mental health disorders and established collaboration with nearly 300 offline healthcare centers for children with autism across the country.
Dec 12, 2024|
JD Health Debuts Merck’s New Diabetes Medication GLUCOPHAGE® XR (Reduce Mass) Online in China
On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering GLUCOPHAGE® XR (Reduce Mass), the metformin hydrochloride extended-release tablets, and became the first online pharmacy in China to provide the new antidiabetic medication developed by Merck. This launch signifies a major milestone in the partnership between JD Health and Merck, which is dedicated to enhancing the online availability and accessibility of innovative treatments for type 2 diabetes patients in China, thereby offering them a more convenient and effective medication experience.
GLUCOPHAGE® has been a cornerstone in the treatment of type 2 diabetes for over 60 years worldwide. The latest version of this medication is designed to enhance patient adherence by reducing the long-term burden of medication administration while maintaining its therapeutic benefits. The use of GSD sustained-release technology extends the time the medication remains in the stomach, reduces gastrointestinal irritation, and improves drug absorption. Additionally, the tablet is now smaller, has reduced volume by 30%, and has been transitioned from a capsule to a round shape, making it easier to swallow. It requires only once-daily administration, significantly enhancing patient convenience and safety.
To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at the 7th China International Import Expo in November. This event followed their partnership agreement in September, which also marked the opening of Merck China’s self-operated flagship store on JD.com.
With a large user base, robust supply chain, and rich medical service resources, JD Health has become a preferred partner to launch many chronic disease medications online. By seamlessly integrating online and offline resources, JD Health ensures that new drug information reaches the right users swiftly, offering convenient purchasing options and improving drug accessibility and usage efficiency. Additionally, JD Health’s extensive logistics network ensures timely and secure delivery of medications, enhancing user experience and building trust.
(vivian.yang@jd.com)
Nov 7, 2024|
CIIE 2024: JD.com to Expand Imports of Specialty Brands, Strengthen Healthcare Partnerships, and Enhance Logistics
At the 7th China International Import Expo (CIIE) on November 5, JD Super, the supermarket division of JD.com, announced a major initiative to broaden its selection of imported specialty. Over the next three years, JD Super plans to introduce over 1,000 new international brands to meet the increasing demand for high-quality, diverse imported goods.
Meeting the Growing Demand for Quality Imports
According to JD Worldwide’s “White Paper on 2024 China Cross-Border Consumption Trends,” more than 80% of Chinese consumers are interested in imported products, with many prioritizing authenticity, quality, and fast delivery. In response, JD has significantly expanded its range of international offerings. During the ongoing Singles’ Day Grand Promotion, sales of cross-border products have surged, with more than 600 brands experiencing a sales increase of over 100% compared to last year.
Strengthening High-Quality Food Partnerships
Demonstrating JD.com’s commitment to sourcing high-quality products, JD Super signed a new procurement agreement at CIIE with Huadong Foods and Teys, a major Australian beef brand under Cargill. Under this agreement, JD Super and Huadong Foods will procure $50 million of Teys beef throughout 2025. This partnership underscores JD’s strategy of collaborating with trusted suppliers to provide high-quality, affordable beef to Chinese consumers.
Delivering Authentic Global Goods Efficiently
JD Logistics has built a robust logistics network that spans bonded, direct mail, and overseas warehouses, facilitating fast deliveries of imported items across categories such as electronics, fashion, beauty, food, and baby products. In many major cities, delivery times have been reduced to under 48 hours.
For instance, JD Super’s partnership with Raub of Malaysia enables the import of Musang King durians, which are harvested at peak ripeness and air-shipped with cold chain logistics for delivery within 24 hours. Additionally, JD.com also secured an early supply of Chilean cherries, available since October, which can be delivered in as little as 30 minutes in many areas through JD NOW, its on-demand retail service.
JD.com’s “JD National Pavilions” program, which features over 150 country-themed flagship stores from more than 70 countries and regions, continues to be a cornerstone of its import strategy. Supported by embassies and reputable organizations, this initiative offers Chinese consumers access to premium products and cultural experiences from around the world. In April, JD launched the JD National Pavilion of Mali, introducing popular items like shea butter and garnering over 40,000 followers.
Expanding Healthcare and Logistics Partnerships
JD Health is also making strides at CIIE by strengthening partnerships with leading global healthcare companies, including Merck, Bayer, and Roche. As “China’s premier online health access point,” JD Health is committed to integrating digital and physical healthcare resources to improve access and convenience for patients.
Key collaborations include initiatives with Haleon to promote brain health and anti-aging for the “silver economy,” with MSD China on a digital diabetes management model, and with Teva Pharmaceuticals to provide patient education for conditions such as tardive dyskinesia (TD) and Huntington’s disease (HD).
On the logistics front, JD Logistics announced plans to double its overseas warehouse space by 2025 and expand its network of bonded and direct mail warehouses. JD Express now serves over 60 countries, enhancing cross-border delivery efficiency and supporting both brands and consumers.
Through these efforts, JD.com reaffirms its commitment to sourcing and delivering authentic, high-quality imported products to Chinese consumers, supported by an advanced supply chain that ensures a superior shopping experience.
(vivian.yang@jd.com)
Fresh Produce Merchants in Shanghai: Attracting more Young Customers via JD
